Home Cart Sign in  
Chemical Structure| 38493-59-3 Chemical Structure| 38493-59-3

Structure of 38493-59-3

Chemical Structure| 38493-59-3

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of [ 38493-59-3 ]

CAS No. :38493-59-3
Formula : C8H9BrO2
M.W : 217.06
SMILES Code : OCC1=CC=C(OC)C(Br)=C1
MDL No. :MFCD01861398
InChI Key :QOUYJSKYVZRGCV-UHFFFAOYSA-N
Pubchem ID :13551346

Safety of [ 38493-59-3 ]

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H315-H319
Precautionary Statements:P305+P351+P338

Computational Chemistry of [ 38493-59-3 ] Show Less

Physicochemical Properties

Num. heavy atoms 11
Num. arom. heavy atoms 6
Fraction Csp3 0.25
Num. rotatable bonds 2
Num. H-bond acceptors 2.0
Num. H-bond donors 1.0
Molar Refractivity 46.76
TPSA ?

Topological Polar Surface Area: Calculated from
Ertl P. et al. 2000 J. Med. Chem.

29.46 Ų

Lipophilicity

Log Po/w (iLOGP)?

iLOGP: in-house physics-based method implemented from
Daina A et al. 2014 J. Chem. Inf. Model.

2.27
Log Po/w (XLOGP3)?

XLOGP3: Atomistic and knowledge-based method calculated by
XLOGP program, version 3.2.2, courtesy of CCBG, Shanghai Institute of Organic Chemistry

1.7
Log Po/w (WLOGP)?

WLOGP: Atomistic method implemented from
Wildman SA and Crippen GM. 1999 J. Chem. Inf. Model.

1.8
Log Po/w (MLOGP)?

MLOGP: Topological method implemented from
Moriguchi I. et al. 1992 Chem. Pharm. Bull.
Moriguchi I. et al. 1994 Chem. Pharm. Bull.
Lipinski PA. et al. 2001 Adv. Drug. Deliv. Rev.

1.95
Log Po/w (SILICOS-IT)?

SILICOS-IT: Hybrid fragmental/topological method calculated by
FILTER-IT program, version 1.0.2, courtesy of SILICOS-IT, http://www.silicos-it.com

2.34
Consensus Log Po/w?

Consensus Log Po/w: Average of all five predictions

2.01

Water Solubility

Log S (ESOL):?

ESOL: Topological method implemented from
Delaney JS. 2004 J. Chem. Inf. Model.

-2.53
Solubility 0.643 mg/ml ; 0.00296 mol/l
Class?

Solubility class: Log S scale
Insoluble < -10 < Poorly < -6 < Moderately < -4 < Soluble < -2 Very < 0 < Highly

Soluble
Log S (Ali)?

Ali: Topological method implemented from
Ali J. et al. 2012 J. Chem. Inf. Model.

-1.93
Solubility 2.53 mg/ml ; 0.0116 mol/l
Class?

Solubility class: Log S scale
Insoluble < -10 < Poorly < -6 < Moderately < -4 < Soluble < -2 Very < 0 < Highly

Very soluble
Log S (SILICOS-IT)?

SILICOS-IT: Fragmental method calculated by
FILTER-IT program, version 1.0.2, courtesy of SILICOS-IT, http://www.silicos-it.com

-3.21
Solubility 0.133 mg/ml ; 0.000611 mol/l
Class?

Solubility class: Log S scale
Insoluble < -10 < Poorly < -6 < Moderately < -4 < Soluble < -2 Very < 0 < Highly

Soluble

Pharmacokinetics

GI absorption?

Gatrointestinal absorption: according to the white of the BOILED-Egg

High
BBB permeant?

BBB permeation: according to the yolk of the BOILED-Egg

Yes
P-gp substrate?

P-glycoprotein substrate: SVM model built on 1033 molecules (training set)
and tested on 415 molecules (test set)
10-fold CV: ACC=0.72 / AUC=0.77
External: ACC=0.88 / AUC=0.94

No
CYP1A2 inhibitor?

Cytochrome P450 1A2 inhibitor: SVM model built on 9145 molecules (training set)
and tested on 3000 molecules (test set)
10-fold CV: ACC=0.83 / AUC=0.90
External: ACC=0.84 / AUC=0.91

Yes
CYP2C19 inhibitor?

Cytochrome P450 2C19 inhibitor: SVM model built on 9272 molecules (training set)
and tested on 3000 molecules (test set)
10-fold CV: ACC=0.80 / AUC=0.86
External: ACC=0.80 / AUC=0.87

No
CYP2C9 inhibitor?

Cytochrome P450 2C9 inhibitor: SVM model built on 5940 molecules (training set)
and tested on 2075 molecules (test set)
10-fold CV: ACC=0.78 / AUC=0.85
External: ACC=0.71 / AUC=0.81

No
CYP2D6 inhibitor?

Cytochrome P450 2D6 inhibitor: SVM model built on 3664 molecules (training set)
and tested on 1068 molecules (test set)
10-fold CV: ACC=0.79 / AUC=0.85
External: ACC=0.81 / AUC=0.87

No
CYP3A4 inhibitor?

Cytochrome P450 3A4 inhibitor: SVM model built on 7518 molecules (training set)
and tested on 2579 molecules (test set)
10-fold CV: ACC=0.77 / AUC=0.85
External: ACC=0.78 / AUC=0.86

No
Log Kp (skin permeation)?

Skin permeation: QSPR model implemented from
Potts RO and Guy RH. 1992 Pharm. Res.

-6.42 cm/s

Druglikeness

Lipinski?

Lipinski (Pfizer) filter: implemented from
Lipinski CA. et al. 2001 Adv. Drug Deliv. Rev.
MW ≤ 500
MLOGP ≤ 4.15
N or O ≤ 10
NH or OH ≤ 5

0.0
Ghose?

Ghose filter: implemented from
Ghose AK. et al. 1999 J. Comb. Chem.
160 ≤ MW ≤ 480
-0.4 ≤ WLOGP ≤ 5.6
40 ≤ MR ≤ 130
20 ≤ atoms ≤ 70

None
Veber?

Veber (GSK) filter: implemented from
Veber DF. et al. 2002 J. Med. Chem.
Rotatable bonds ≤ 10
TPSA ≤ 140

0.0
Egan?

Egan (Pharmacia) filter: implemented from
Egan WJ. et al. 2000 J. Med. Chem.
WLOGP ≤ 5.88
TPSA ≤ 131.6

0.0
Muegge?

Muegge (Bayer) filter: implemented from
Muegge I. et al. 2001 J. Med. Chem.
200 ≤ MW ≤ 600
-2 ≤ XLOGP ≤ 5
TPSA ≤ 150
Num. rings ≤ 7
Num. carbon > 4
Num. heteroatoms > 1
Num. rotatable bonds ≤ 15
H-bond acc. ≤ 10
H-bond don. ≤ 5

0.0
Bioavailability Score?

Abbott Bioavailability Score: Probability of F > 10% in rat
implemented from
Martin YC. 2005 J. Med. Chem.

0.55

Medicinal Chemistry

PAINS?

Pan Assay Interference Structures: implemented from
Baell JB. & Holloway GA. 2010 J. Med. Chem.

0.0 alert
Brenk?

Structural Alert: implemented from
Brenk R. et al. 2008 ChemMedChem

0.0 alert: heavy_metal
Leadlikeness?

Leadlikeness: implemented from
Teague SJ. 1999 Angew. Chem. Int. Ed.
250 ≤ MW ≤ 350
XLOGP ≤ 3.5
Num. rotatable bonds ≤ 7

No; 1 violation:MW<1.0
Synthetic accessibility?

Synthetic accessibility score: from 1 (very easy) to 10 (very difficult)
based on 1024 fragmental contributions (FP2) modulated by size and complexity penaties,
trained on 12'782'590 molecules and tested on 40 external molecules (r2 = 0.94)

1.32

Application In Synthesis of [ 38493-59-3 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 38493-59-3 ]

[ 38493-59-3 ] Synthesis Path-Upstream   1~9

  • 1
  • [ 35450-37-4 ]
  • [ 38493-59-3 ]
YieldReaction ConditionsOperation in experiment
98% With diisobutylaluminium hydride In tetrahydrofuran; hexane at -78 - 0℃; for 1 h; Inert atmosphere To a solution of methyl 3-bromo-4-methoxybenzoate (12, 2.00 g, 8.16 mmol) in THF (20 mL) was added DIBAL–H (1.00 M in hexane, 20.4 mL) at −78 °C. The mixture was stirred at −78 °C for 30 min and 0 °C for 30 min. To the reaction mixture at −78 °C was added methanol (10 mL) dropwisely followed by saturated aqueous Rochelle salt solution (16 mL) and EtOAc (20 mL). After being stirred at room temperature for 2 h, the aqueous layer was extracted with EtOAc. The combined organic layers were dried over Na2SO4, and then concentrated in vacuo. Purification on silica gel column chromatography (hexane/EtOAc=2:1) gave 13 (1.73 g, 7.96 mmol, 98percent) as a colorless solid; Rf 0.17 (hexane/EtOAc=3:1); 1H NMR (300 MHz, CDCl3) δ 7.57 (1H, d, J=2.2 Hz, H18), 7.27 (1H, dd, J=8.6, 2.2 Hz, H15), 6.88 (1H, d, J=8.6 Hz, H16), 4.61 (2H, s, H13), 3.90 (3H, s, OMe); 13C NMR (75 MHz, CDCl3) δ 55.5, 134.6, 132.4, 112.0, 111.8, 64.4, 56.4; EIMS (m/z) calcd for C8H9BrO2 [M]+ 215.98, found 216.05
References: [1] Tetrahedron, 2013, vol. 69, # 13, p. 2807 - 2815.
  • 2
  • [ 34841-06-0 ]
  • [ 38493-59-3 ]
References: [1] Bioorganic and Medicinal Chemistry, 2010, vol. 18, # 18, p. 6874 - 6885.
[2] Patent: JP2005/120047, 2005, A, . Location in patent: Page/Page column 106.
[3] Chemical Communications, 1999, # 3, p. 287 - 288.
[4] Tetrahedron Letters, 2013, vol. 54, # 21, p. 2737 - 2739.
[5] Journal of the Chemical Society, 1938, p. 1780,1782.
[6] Journal of the Chemical Society [Section] C: Organic, 1970, p. 2234 - 2238.
[7] Patent: US6582351, 2003, B1, .
[8] Chemical Communications, 2014, vol. 50, # 40, p. 5254 - 5257.
[9] Patent: CN106632070, 2017, A, . Location in patent: Paragraph 0024-0025.
  • 3
  • [ 443776-91-8 ]
  • [ 38493-59-3 ]
References: [1] Synthesis, 2005, # 4, p. 547 - 550.
  • 4
  • [ 621-59-0 ]
  • [ 38493-59-3 ]
References: [1] Synthesis, 2005, # 4, p. 547 - 550.
  • 5
  • [ 157790-73-3 ]
  • [ 38493-59-3 ]
References: [1] Synthesis, 2005, # 4, p. 547 - 550.
  • 6
  • [ 105-13-5 ]
  • [ 104-92-7 ]
  • [ 38493-59-3 ]
  • [ 123-11-5 ]
References: [1] Journal of Organic Chemistry, 2000, vol. 65, # 12, p. 3880 - 3881.
  • 7
  • [ 121-98-2 ]
  • [ 38493-59-3 ]
References: [1] Tetrahedron, 2013, vol. 69, # 13, p. 2807 - 2815.
  • 8
  • [ 99-96-7 ]
  • [ 38493-59-3 ]
References: [1] Tetrahedron, 2013, vol. 69, # 13, p. 2807 - 2815.
  • 9
  • [ 99-58-1 ]
  • [ 38493-59-3 ]
References: [1] Angewandte Chemie - International Edition, 2019, vol. 58, # 15, p. 4992 - 4997[2] Angew. Chem., 2019, vol. 131, p. 5046 - 5051,6.
 

Historical Records

Technical Information

Categories

Related Functional Groups of
[ 38493-59-3 ]

Aryls

Chemical Structure| 17100-64-0

A145462 [17100-64-0]

(4-Bromo-3-methoxyphenyl)methanol

Similarity: 0.96

Chemical Structure| 29578-83-4

A131087 [29578-83-4]

1-Bromo-3-methoxy-5-methylbenzene

Similarity: 0.89

Chemical Structure| 14804-31-0

A136397 [14804-31-0]

4-Bromo-1-methoxy-2-methylbenzene

Similarity: 0.89

Chemical Structure| 61367-62-2

A197834 [61367-62-2]

4-Bromo-3,5-dimethoxybenzyl alcohol

Similarity: 0.88

Chemical Structure| 17102-63-5

A471029 [17102-63-5]

4-Bromo-2-methoxybenzyl alcohol

Similarity: 0.87

Bromides

Chemical Structure| 17100-64-0

A145462 [17100-64-0]

(4-Bromo-3-methoxyphenyl)methanol

Similarity: 0.96

Chemical Structure| 29578-83-4

A131087 [29578-83-4]

1-Bromo-3-methoxy-5-methylbenzene

Similarity: 0.89

Chemical Structure| 14804-31-0

A136397 [14804-31-0]

4-Bromo-1-methoxy-2-methylbenzene

Similarity: 0.89

Chemical Structure| 61367-62-2

A197834 [61367-62-2]

4-Bromo-3,5-dimethoxybenzyl alcohol

Similarity: 0.88

Chemical Structure| 17102-63-5

A471029 [17102-63-5]

4-Bromo-2-methoxybenzyl alcohol

Similarity: 0.87

Ethers

Chemical Structure| 17100-64-0

A145462 [17100-64-0]

(4-Bromo-3-methoxyphenyl)methanol

Similarity: 0.96

Chemical Structure| 29578-83-4

A131087 [29578-83-4]

1-Bromo-3-methoxy-5-methylbenzene

Similarity: 0.89

Chemical Structure| 14804-31-0

A136397 [14804-31-0]

4-Bromo-1-methoxy-2-methylbenzene

Similarity: 0.89

Chemical Structure| 61367-62-2

A197834 [61367-62-2]

4-Bromo-3,5-dimethoxybenzyl alcohol

Similarity: 0.88

Chemical Structure| 17102-63-5

A471029 [17102-63-5]

4-Bromo-2-methoxybenzyl alcohol

Similarity: 0.87

Alcohols

Chemical Structure| 17100-64-0

A145462 [17100-64-0]

(4-Bromo-3-methoxyphenyl)methanol

Similarity: 0.96

Chemical Structure| 61367-62-2

A197834 [61367-62-2]

4-Bromo-3,5-dimethoxybenzyl alcohol

Similarity: 0.88

Chemical Structure| 17102-63-5

A471029 [17102-63-5]

4-Bromo-2-methoxybenzyl alcohol

Similarity: 0.87

Chemical Structure| 2737-19-1

A391212 [2737-19-1]

2-Bromo-5-(hydroxymethyl)phenol

Similarity: 0.84

Chemical Structure| 150192-39-5

A113087 [150192-39-5]

(2-Bromo-5-methoxyphenyl)methanol

Similarity: 0.83